ArticleTranslational cancer research2026

Assessing the utility of ctDNA as a prognostic marker in advanced ER-positive/HER2-negative breast cancer.

Moumita Chaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.